The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((9-methyl-9H-carbazol-3-yl)methylene)indolin-2-one ID: ALA2206027
PubChem CID: 71459624
Max Phase: Preclinical
Molecular Formula: C22H16N2O
Molecular Weight: 324.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c2ccccc2c2cc(/C=C3\C(=O)Nc4ccccc43)ccc21
Standard InChI: InChI=1S/C22H16N2O/c1-24-20-9-5-3-7-16(20)17-12-14(10-11-21(17)24)13-18-15-6-2-4-8-19(15)23-22(18)25/h2-13H,1H3,(H,23,25)/b18-13-
Standard InChI Key: JMMZHWFEOFADJP-AQTBWJFISA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
29.6568 -8.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6557 -8.9914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3637 -9.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3620 -7.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0706 -8.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0708 -8.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8495 -9.2397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3305 -8.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8491 -7.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1477 -8.5769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1013 -7.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9006 -6.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4439 -7.5784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9436 -6.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1471 -6.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4954 -6.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2438 -7.4057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3102 -6.6306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.5622 -7.4054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9047 -7.8813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9889 -8.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7298 -9.0171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3875 -8.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3000 -7.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7904 -5.9694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
9 11 2 0
11 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 2 0
17 20 1 0
19 18 1 0
18 16 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
18 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.38Molecular Weight (Monoisotopic): 324.1263AlogP: 4.82#Rotatable Bonds: 1Polar Surface Area: 34.03Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.31CX Basic pKa: ┄CX LogP: 4.61CX LogD: 4.61Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.50Np Likeness Score: -0.29
References 1. Amombo GM, Kramer T, Lo Monte F, Göring S, Fach M, Smith S, Kolb S, Schubenel R, Baumann K, Schmidt B.. (2012) Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3., 22 (24): [PMID:23107479 ] [10.1016/j.bmcl.2012.10.016 ]